Trending
November 19, 2024 Kevin Krause Appointed CEO of ArrePAthNovember 14, 2024 myBiometry Secures $5M to Seek Regulatory Sanction for Device for Asthma PatientsNovember 12, 2024 Avalo Therapeutics Closes $69.4 Million FinancingNovember 4, 2024 Cornucopian Capital Joins $20M Round for Archon BiosciencesOctober 30, 2024 Orthobond Appoints George Landau as EVP, Business Development and Commercialization